Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea

European Journal of Cancer Prevention

Volumn 18, Issue 1, 2009, Pages 56-61

  Oh, Jin Kyoung ^a,b   Franceschi, Silvia ^h   Kim, Bu Kyung ^a   Kim, Ji Young ^a   Ju, Young Hee ^a,c   Hong, Eun Kyung ^a   Chang, Young Chul ^d   Rha, Seo Hee ^e   Kim, Hyun Ho ^e   Kim, Jung Hye ^f   Kim, Chang Young ^g   Shin, Hai Rim ^a,h  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

^c Korean Nurses Association   (South Korea)

^d Planned Population Federation of Korea ^*

^e Dong A University   (South Korea)

^f Department of Obstetrics and Gynecology Ilsin Christian Hospital   (South Korea)

^g West Suwon Hospital   (South Korea)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Chlamydia trachomatis; Human papillomavirus; Prevalence; South Korea

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CROSS REACTION; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; KOREA; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; KOREA; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 58149239815     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328305a0a6     Document Type: Article

References (35)

1. Adams EJ, Charlett A, Edmunds WJ, Hughes G (2004). Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect 80:354-362.
2. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, et al. (2001). Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. J Am Med Assoc 285:47-51.
3. Chesson HW, Harrison P, Stall R (2003). Changes in alcohol consumption and in sexually transmitted disease incidence rates in the United States: 1983-1998. J Stud Alcohol 64:623-630.
4. Cook RL, Clark DB (2005). Is there an association between alcohol consumption and sexually transmitted diseases? A systematic review. Sex Transm Dis 32:156-164.
5. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. (2003). Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362:1871-1876.
6. Cuzick J, Mayrand MH, Ronco G, Snijders P, Wardle J (2006). Chapter 10: new dimensions in cervical cancer screening. Vaccine 24 (Suppl 3):S90-S97.
7. De Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453-459.
8. Franceschi S, Smith JS, Van den Brule A, Herrero R, Arslan A, Anh PT, et al. (2007). Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 34:563-569.
9. Girianelli VR, Thuler LC, Szklo M, Donato A, Zardo LM, Lozana JA, et a/. (2006). Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer. Eur J Cancer Prev 15:504-510.
10. Holmes J, Hemmett L, Garfield S (2005). The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies. Eur J Health Econ 6:30-37.
11. Iftner T, Villa LL (2003). Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst 31:80-88.
12. Korean Centers for Disease Control and Prevention (KCDC) (2005). Communicable diseases monthly report Vol. 16. Seoul: KCDC.
13. Korean Institute for Health and Social Affairs (KIHSA) (2007). In-depth analyses of the Third National Health and Nutrition Examination Survey (2005): the health interview and health behavior survey part. Seoul: KIHSA.
14. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, et al. (2000). Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85:35-39.
15. Lee SJ, Cho YH, Kim CS, Shim BS, Cho IR, Chung Jl, et al. (2004). Screening for Chlamydia and gonorrhea by strand displacement amplification in homeless adolescents attending youth shelters in Korea. J Korean Med Sci 19:495-500.
16. Lee SJ, Cho YH, Ha US, Kim SW, Yoon MS, Bae K (2005). Sexual behavior survey and screening for chlamydia and gonorrhea in university students in South Korea. Int J Urol 12:187-193.
17. Molano M, Van den Brule A, Plummer M, Weiderpass E, Posso H, Arslan A, et al. (2003). Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year followup study. Am J Epidemiol 158:486-494.
18. Murthy NS, Mathew A (2000). Risk factors for pre-cancerous lesions of the cervix. Eur J Cancer Prev 9:5-14.
19. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, et al. (2005). Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162:668-675.
20. Seo KA, Lee HJ, Lee SW, Yoon CG, Kim JH, Park DC, et al. (2004). Prevalence of Chlamydia trachomatis and relation with human papillomavirus. Korean J Obstet Gynecol 47:670-677.
21. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. (2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 103:413-421.
22. Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, et al. (2004). Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 190:468-476.
23. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. (2005). Nationwide cancer incidence in Korea, 1999 - 2001; First resulting using the national cancer incidence database. Cancer Res Treat 37:325-331.
24. Shin HR, Jung KW, Won YJ, Kong HJ, Yim SH, Seo SW, et al. (2007). National cancer incidence for the year 2002 in Korea. Cancer Res Treat 39: 139-149.
25. Silins I, Ryd W, Strand A, Wadell G, Tornberg S, Hansson BG, et al. (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116:110-115.
26. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, et al. (2002). Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185:324-331.
27. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, et al. (2004). Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111:431 -439.
28. Stevens MP, Garland SM, Rudland E, Tan J, Quinn MA, Tabrizi SN (2007). Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 45:2130-2137.
29. Vajdic CM, Middleton M, Bowden FJ, Fairley CK, Kaldor JM (2005). The prevalence of genital Chlamydia trachomatis in Australia 1997-2004: a systematic review. Sex Health 2:169-183.
30. Vernon SD, Unger ER, Williams D (2000). Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38:651-655.
31. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
32. Wallin KL, Wiklund F, Luostarinen T, Angstrom T, Anttila T, Bergman F, et al. (2002). A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 101:371-374.
33. Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, et al. (2002). The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 51:1021-1031.
34. World Health Organization (WHO) (2001). Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: WHO.
35. Wilson JS, Honey E, Templeton A, Paavonen J, Mardh PA, Stray-Pedersen B (2002). A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 8:385-394.